You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

A popular pharmaceutical intervention for weight loss may also have the potential to curb alcoholism, as researchers observed a “commonality of function.” Between those who swear by […] ...

“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the natural hormone GLP-1, which plays a crucial role in glucose regulation, ...

A new study suggests that weight-loss drugs may significantly reduce alcohol consumption in people with obesity.

A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has ...

New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is not associated with increased risk of psychiatric adverse events or worsening ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the drugs for people with eating disorders.

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared with weight-loss surgery, researchers report ...